All News

Rising healthcare costs and challenges with access to care have given rise to innovations in healthcare and new partnerships. Now, Blue Cross and Blue Shield of North Carolina (Blue Cross NC) is partnering with Duke University Health System (Duke Health) to create a new health insurance company to meet the needs of seniors.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

After leaving the FDA, Commissioner Scott Gottlieb, MD, will return to conservative think tank American Enterprise Institute; the Trump administration is urging Alaska to become the first state to change its Medicaid program funding to a block grant; CVS is expanding its same-day prescription delivery service to 36 states and Washington, DC.

This week, the top managed care news included courts rejecting multiple health initiatives from the Trump administration; Congress heard more about rising insulin prices; a new agreement seeks standards for reporting social determinants of health.

Researchers evaluated differences in effectiveness of 2 couple-based preventive interventions aimed to reduce the spread of HIV and sexually transmitted infections among individuals in community supervision programs.

Older men are less likely than older women to have their bone mineral density measured and be prescribed treatment for osteoporosis.

Based on recently published results of the REDUCE-IT study, pharmacuetical company Amarin has submitted a supplemental new drug application (sNDA) to the FDA for an expanded label for its leading drug Vascepa. Also, the American Diabetes Association has included the drug in a mid-year update to its 2019 Standards of Medical Care in Diabetes.

Women with multiple sclerosis (MS) who give birth do not face an increased risk of relapses postpartum. New research being presented in May at the American Academy of Neurology annual meeting found the time right after pregnancy is one of the periods in which MS symptoms may not flare back up.

The Leapfrog Group has launched its first annual survey on patient safety and quality in ambulatory surgery centers.

The FDA is warning of a potential seizure risk associated with e-cigarettes, especially among asolescents and young adults; Sorrento Therapeutics is suing its business partner, alleging he purchased and then tried to prevent the release of their cancer drug; states are suing the Trump administration over plans to loosen school lunch nutrition standards.

While medical advances have improved lifespan and quality of life for patients with HIV, there are still opportunities for strategies that address both medication safety and costs.

Today, the Health Care Payment Learning & Action Network (LAN) launched the Roadmap for Driving High Performance in Alternative Payment Models. The roadmap is designed as a customizable, interactive tool to assist healthcare payers, providers, and various stakeholders in navigating alternative payment model (APM) implementation.

Cigna and its pharmacy benefit manager Express Scripts said they are launching a program for patients with diabetes in its commercial plans so that they pay no more than $25 for a 30-day supply of insulin.

Medicare Advantage (MA) plans will see a 2.53% increase in payments in 2020; the FDA is developing a framework for regulatory oversight of artificial intelligence (AI); a federal court is allowing Wisconsin to withdraw 2 lawsuits from the state challenging the Affordable Care Act (ACA).

The American Medical Association (AMA) and UnitedHealthcare are teaming up to standardize how data on social determinants of health (SDOH) are collected, processed, and integrated.

During National Public Health Week, a webcast held by the American Public Health Association offered perspectives and stories of grassroots movements that are changing the lives of the people in their region.

A House of Representatives subcommittee heard from stakeholders about the impact of the rising cost of insulin.

Insurance status was found to potentially affect whether patients who used emergency department services were transferred to other hospitals, discharged, or admitted to hospitals.

The American Medical Association and the AARP issue briefs in defense of the Affordable Care Act (ACA), while President Trump is delaying an ACA alternative until after the 2020; top hospitals offer unproven stem cell treatments; the measles outbreak hits a new high.

Data from a phase 2 study demonstrated that high-grade neuroendocrine carcinoma had a 42% overall response rate to the combination of nivolumab and ipilimumab.

The availability and affordability of healthcare is the most pressing concern of Americans, Gallup says in latest poll.

A new study in Health Affairs comes within a week of a federal ruling that found Medicaid work requirements in Arkansas and Kentucky failed to meet requirements of the 1965 law creating the program.

A recent literature review assessed the efficacy of beta-blockers to prevent migraine and tension headache. It found that propranolol worked better than placebo for episodic migraine headaches, but the evidence for efficacy in tension headaches was limited.

By providing case management, self-management education, and skills training, integrated disease management is associated with fewer exacerbations and improved quality of life (QOL) among patients with chronic obstructive pulmonary disease (COPD) enagaged in primary care.

CMS approves Utah Medicaid work requirements after a federal judge overturns rules for Arkansas and Kentucky; youth suicide risk in Missouri grows with the shift to managed care; CDC says a goal of eliminating tuberculosis by end of 21st century unlikely.

As novel therapies drive up the cost of drugs, it is becoming increasingly difficult for community oncologists to keep costs below value-based care program targets, according to a new survey from Integra Connect.

A recent study found that aerobic exercise may be associated with a reduced number of migraine days in patients who experience migraine.

Researchers from South Korea said they have developed a next-generation sequencing (NGS) assay to detect somatic mutations, translocations, and germline mutations in a single assay for the purpose of supplementing or replacing conventional tests in patients with myeloid neoplasms.

A comprehensive genomic analysis of acute erythoid leukemia (AEL) found that 45% of patients had mutations in signaling pathways that drive uncontrolled cell growth, and evidence shows these leukemias may respond to existing precision treatments.